FDA data Registry peer set 3 peers

Alternatives to alogliptin

3 same-class SPL records vs alogliptin - uses, FAERS reaction fields, and OTC/Rx flags from public FDA sources.

View alogliptin → All alternatives

Brand: Nesina

DPP-4 Inhibitor Prescription 3 alternatives found

About alogliptin

View full alogliptin profile →

3 DPP-4 Inhibitor peers (wide set)

linagliptin

Rx

Tradjenta

saxagliptin

Rx

Onglyza

sitagliptin

Rx

Januvia

Compare alogliptin vs linagliptin side-by-side →

alogliptin vs linagliptin & saxagliptin · FAERS reaction fields

FAERS top-reaction field "Nausea" shows the widest count spread between alogliptin and linagliptin, saxagliptin, sitagliptin in this extract (3,666-report gap on that field). Counts are exposure-weighted submissions, not prevalence rates.

Side Effect alogliptin linagliptinsaxagliptinsitagliptin
Diarrhoea 134 1,196 328 3,470
Nausea 124 1,138 372 3,790
Vomiting 110 875 227 2,317
Acute Kidney Injury 101 772 213 2,158
Pemphigoid 101 - - -
Malaise 93 789 - 1,898
Rash 92 - 217 -
Blood Glucose Increased 86 1,326 401 4,453

"-" means no reports for that reaction. Report counts reflect total FAERS submissions, not prevalence rates.

alogliptin peer mix vs class inventory

Peer mix

0 OTC and 3 Rx SPL records in this peer set (3 total). Class inventory for DPP-4 Inhibitor: 4 drugs.

Frequently Asked Questions

What same-class SPL records sit beside alogliptin? ▼
This registry lists 3 DPP-4 Inhibitor medication records beside alogliptin, including linagliptin, saxagliptin, sitagliptin. Grouping is therapeutic-class indexing from openFDA/SPL, not a product recommendation.

Reading a wide DPP-4 Inhibitor peer set (3 records)

alogliptin (Nesina) sits in a wide DPP-4 Inhibitor peer set (3 of 3 class peers shown).

Top FAERS reaction fields for alogliptin total 1,007 reports across 10 reactions, set beside linagliptin, saxagliptin, sitagliptin. Counts are exposure-weighted submissions, not per-patient risk.

Registry note: Therapeutic-class peer lists are registry indexes, not prescribing advice. This information is for educational purposes only and is not a substitute for professional medical advice. Do not stop or change your medication without talking to your doctor or pharmacist.

Full alogliptin profile →

Field note for alogliptin: see also the generic vs brand label guide when reading Nesina SPL strings.

Read our methodology - how this data is sourced, computed, and verified.